Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.

Arimany-Nardi, C; Koepsell, H; Pastor-Anglada, M

Arimany-Nardi, C; Koepsell, H; Pastor-Anglada, M.

Afiliação

Arimany-Nardi C; Molecular Physiology and Experimental Therapeutics, Department of Biochemistry and Molecular Biology, Institute of Biomedicine (IBUB), University of Barcelona and Oncology Program, National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos III, Barcelona, Spain.
Koepsell H; Department of Molecular Plant Physiology and Biophysics, Julius-von-Sachs-Institute, University Würzburg, Würzburg, Germany.
Pastor-Anglada M; Molecular Physiology and Experimental Therapeutics, Department of Biochemistry and Molecular Biology, Institute of Biomedicine (IBUB), University of Barcelona and Oncology Program, National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBER EHD), Instituto de Salud Carlos III, Barcelona, Spain.

Pharmacogenomics J ; 15(6): 473-87, 2015 Dec.

Article em En | MEDLINE | ID: mdl-26526073

Assuntos

Interações Medicamentosas/genética; Transportador 1 de Cátions Orgânicos/genética; Preparações Farmacêuticas/metabolismo; Polimorfismo Genético/genética; Animais; Humanos; Farmacogenética/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Preparações Farmacêuticas / Transportador 1 de Cátions Orgânicos / Interações Medicamentosas Limite: Animals / Humans Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google